Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.
about
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV InfectionImmunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy.Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.PharmGKB summary: gemcitabine pathwaySLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients.DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study.
P2860
Q26749811-5BAB3C70-70FA-4617-A32B-B371EF039F3BQ30238470-79883F98-235C-4F2B-B1C1-C73F0FC61AF6Q30244166-9826DCB7-C567-40E3-A033-E81B90786883Q33442358-D86D5474-3434-4C7A-ABEA-2D8659A886EEQ34435450-BB712E3B-6FD9-489E-83D2-ACBDDA56B13EQ37507420-C1DD5797-4876-42C9-AB43-913FEE860CBAQ39047242-BE71C4FE-B799-45A4-B20D-6ABE9FA4FEB5Q47129097-E1E1A85D-80BF-409C-A3C9-07DC7896C44C
P2860
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@en
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@nl
type
label
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@en
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@nl
prefLabel
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@en
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@nl
P2093
P2860
P356
P1433
P1476
Pathway-based pharmacogenomics ...... in patients with solid tumors.
@en
P2093
Amit K Mitra
Amit Khatri
Arkadiusz Z Dudek
Edward W Greeno
Jatinder K Lamba
Keith M Skubitz
Mark N Kirstein
Robert A Kratzke
P2860
P304
P356
10.2217/PGS.12.81
P577
2012-07-01T00:00:00Z